These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28534193)

  • 1. Antagonist-perturbation mechanism for activation function-2 fixed motifs: active conformation and docking mode of retinoid X receptor antagonists.
    Tsuji M
    J Comput Aided Mol Des; 2017 Jun; 31(6):577-585. PubMed ID: 28534193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The "Phantom Effect" of the Rexinoid LG100754: structural and functional insights.
    Sato Y; Ramalanjaona N; Huet T; Potier N; Osz J; Antony P; Peluso-Iltis C; Poussin-Courmontagne P; Ennifar E; Mély Y; Dejaegere A; Moras D; Rochel N
    PLoS One; 2010 Nov; 5(11):e15119. PubMed ID: 21152046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HX531, a retinoid X receptor antagonist, inhibited the 9-cis retinoic acid-induced binding with steroid receptor coactivator-1 as detected by surface plasmon resonance.
    Kanayasu-Toyoda T; Fujino T; Oshizawa T; Suzuki T; Nishimaki-Mogami T; Sato Y; Sawada J; Inoue K; Shudo K; Ohno Y; Yamaguchi T
    J Steroid Biochem Mol Biol; 2005 Mar; 94(4):303-9. PubMed ID: 15857749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of RXR function through ligand design.
    Pérez E; Bourguet W; Gronemeyer H; de Lera AR
    Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of retinoid X receptor transcriptional antagonism.
    Cavasotto CN; Liu G; James SY; Hobbs PD; Peterson VJ; Bhattacharya AA; Kolluri SK; Zhang XK; Leid M; Abagyan R; Liddington RC; Dawson MI
    J Med Chem; 2004 Aug; 47(18):4360-72. PubMed ID: 15317450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthesis of tethered ligand dimers for PPARgamma-RXR protein heterodimers.
    Mohler DL; Shen G
    Org Biomol Chem; 2006 Jun; 4(11):2082-7. PubMed ID: 16729120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and SAR of Natural-Product-Inspired RXR Agonists with Heterodimer Selectivity to PPARδ-RXR.
    Nakashima KI; Yamaguchi E; Noritake C; Mitsugi Y; Goto M; Hirai T; Abe N; Sakai E; Oyama M; Itoh A; Inoue M
    ACS Chem Biol; 2020 Jun; 15(6):1526-1534. PubMed ID: 32374156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the inhibition of AKR1B10 by the C3 brominated TTNPB derivative UVI2008.
    Ruiz FX; Crespo I; Álvarez S; Porté S; Giménez-Dejoz J; Cousido-Siah A; Mitschler A; de Lera ÁR; Parés X; Podjarny A; Farrés J
    Chem Biol Interact; 2017 Oct; 276():174-181. PubMed ID: 28161411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of antagonists on the conformational exchange of the retinoid X receptor alpha ligand-binding domain.
    Lu J; Dawson MI; Hu QY; Xia Z; Dambacher JD; Ye M; Zhang XK; Li E
    Magn Reson Chem; 2009 Dec; 47(12):1071-80. PubMed ID: 19757405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diphenylamine-based retinoid antagonists: regulation of RAR and RXR function depending on the N-substituent.
    Ohta K; Kawachi E; Fukasawa H; Shudo K; Kagechika H
    Bioorg Med Chem; 2011 Apr; 19(8):2501-7. PubMed ID: 21459577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.
    Zhang H; Li L; Chen L; Hu L; Jiang H; Shen X
    J Mol Biol; 2011 Mar; 407(1):13-20. PubMed ID: 21262235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of retinoid X receptor partial agonistic action of 1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid and structural development to increase potency.
    Ohsawa F; Yamada S; Yakushiji N; Shinozaki R; Nakayama M; Kawata K; Hagaya M; Kobayashi T; Kohara K; Furusawa Y; Fujiwara C; Ohta Y; Makishima M; Naitou H; Tai A; Yoshikawa Y; Yasui H; Kakuta H
    J Med Chem; 2013 Mar; 56(5):1865-77. PubMed ID: 23391145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of benzofused heterocyclic RXR modulators.
    Gernert DL; Neel DA; Boehm MF; Leibowitz MD; Mais DA; Michellys PY; Rungta D; Reifel-Miller A; Grese TA
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2759-63. PubMed ID: 15125928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RXR antagonism induces G0 /G1 cell cycle arrest and ameliorates obesity by up-regulating the p53-p21(Cip1) pathway in adipocytes.
    Nakatsuka A; Wada J; Hida K; Hida A; Eguchi J; Teshigawara S; Murakami K; Kanzaki M; Inoue K; Terami T; Katayama A; Ogawa D; Kagechika H; Makino H
    J Pathol; 2012 Apr; 226(5):784-95. PubMed ID: 21956786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in mice.
    Yamamoto A; Kakuta H; Sugimoto Y
    Int Immunopharmacol; 2014 Sep; 22(1):204-8. PubMed ID: 24975659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling, synthesis and biological evaluation of potential retinoid X receptor-selective agonists: novel halogenated analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene).
    Furmick JK; Kaneko I; Walsh AN; Yang J; Bhogal JS; Gray GM; Baso JC; Browder DO; Prentice JL; Montano LA; Huynh CC; Marcus LM; Tsosie DG; Kwon JS; Quezada A; Reyes NM; Lemming B; Saini P; van der Vaart A; Groy TL; Marshall PA; Jurutka PW; Wagner CE
    ChemMedChem; 2012 Sep; 7(9):1551-66. PubMed ID: 22927238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docking simulations suggest that all-trans retinoic acid could bind to retinoid X receptors.
    Tsuji M; Shudo K; Kagechika H
    J Comput Aided Mol Des; 2015 Oct; 29(10):975-88. PubMed ID: 26384496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An antagonist of the retinoid X receptor reduces the viability of Trichuris muris in vitro.
    Hurst RJ; Hopwood T; Gallagher AL; Partridge FA; Burgis T; Sattelle DB; Else KJ
    BMC Infect Dis; 2014 Sep; 14():520. PubMed ID: 25261877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factors Nur77 and retinoid X receptors participate in amphetamine-induced locomotor activities.
    Bourhis E; Maheux J; Paquet B; Kagechika H; Shudo K; Rompré PP; Rouillard C; Lévesque D
    Psychopharmacology (Berl); 2009 Mar; 202(4):635-48. PubMed ID: 18843482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors.
    Giner XC; Cotnoir-White D; Mader S; Lévesque D
    FASEB J; 2015 Oct; 29(10):4256-67. PubMed ID: 26148973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.